ClinicalTrials.gg
CompletedNCT07872748Updated Oct 16, 2026

PNF and Shoulder Function in Adhesive Capsulitis

An interventional study of PNF Exercise and Exercise in Proprioceptive Neuromuscular Facilitation and Adhesive Capsulitis, sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Ondokuz Mayıs University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Jan 2024, registered Oct 2026).
Updated Oct 16, 2026Primary outcomes revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aimed to investigate the effects of Proprioceptive Neuromuscular Facilitation (PNF) on range of motion, pain, and shoulder function in patients with frozen shoulder.

02

Conditions studied

  • Proprioceptive Neuromuscular Facilitation
  • Adhesive Capsulitis

Browse trials for

03

In context

Bursitis

417 studies on the registry are indexed under Bursitis; 112 are open to participants now.

This study's enrollment of 32 is below the median of 45 across 376 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Ondokuz Mayıs University is the lead sponsor of 272 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants were eligible if they met all of the following criteria:

  • aged 18 years or older;
  • clinically diagnosed with adhesive capsulitis (frozen shoulder) and classified as stage II or III;
  • had other shoulder pathologies excluded by magnetic resonance imaging (MRI);
  • had experienced shoulder pain for at least 3 months
  • voluntarily participated in the study and provided written informed consent.

Exclusion criteria

Exclusion Criteria:

  • concomitant shoulder pathologies such as rotator cuff tears or tendinitis
  • neurological disorders that could affect shoulder function
  • a history of shoulder surgery
  • inability to comply with the exercise program
  • mental or cognitive impairments
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    PNF Group

    Other: PNF Exercise

  • Active comparator
    Conventional Physiotherapy Group

    Other: Exercise

Interventions

  • OtherPNF Exercise

    (PNF) Proprioceptive Neuromuscular Facilitation

  • OtherExercise

    Conventional Physiotherapy

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS)

    Pain intensity will be assessed using the Visual Analog Scale, which ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and a worse outcome.

    Time frame: through study completion, an average of 1 year

  2. Shoulder Pain and Disability Index (SPADI)

    Shoulder pain and disability will be assessed using the Shoulder Pain and Disability Index, which consists of 13 items divided into two subscales: pain (5 items) and disability (8 items). The total score ranges from 0 to 100, with higher scores indicating greater pain and disability and a worse outcome.

    Time frame: through study completion, an average of 1 year

  3. Simple Shoulder Test (SST)

    Shoulder function will be assessed using the Simple Shoulder Test, which consists of 12 yes/no questions regarding shoulder function. The total score ranges from 0 to 12, with higher scores indicating better shoulder function and a better outcome.

    Time frame: through study completion, an average of 1 year

  4. Lateral Scapular Slide Test (LSST)

    Scapular position will be assessed using the Lateral Scapular Slide Test, which measures the distance between the inferior angle of the scapula and the corresponding thoracic spinous process at specified shoulder positions. The measurement is recorded in centimeters. As this test measures scapular position rather than a scored scale, there is no fixed minimum or maximum score. Greater side-to-side differences in scapular distance indicate greater scapular asymmetry, whereas smaller differences indicate greater symmetry. The interpretation of this measure should consider the measurement position and the clinical context.

    Time frame: through study completion, an average of 1 year

  5. Range of Motion (ROM)

    Shoulder range of motion will be assessed using goniometric measurements and recorded in degrees (°). The minimum and maximum values depend on the direction of movement assessed and the measurement protocol; therefore, no single fixed range applies to all shoulder movements. For shoulder flexion, extension, abduction, internal rotation, and external rotation, higher values generally indicate greater range of motion and a better outcome, provided that the movement is pain-free and does not involve compensatory movements.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Ondokuz Mayıs University
    Samsun, Samsun 55139, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Also revised
primary outcomes
Registered
First appeared on the registry
Oct 14, 2026
Show all 2 updates
  1. Oct 16, 2026
    Primary outcomes Revised (5 changes)
    + 1 other change: identifiers
  2. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872748
Responsible party
Deniz Çakır (Research Assistant, Ondokuz Mayıs University) — Principal investigator
First posted
Oct 14, 2026
Start date
Jan 1, 2024
Primary completion
Jan 1, 2025
Completion
Dec 1, 2025
Last update
Oct 16, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion